neurim pharmaceuticals eec ltd

摘要

the invention relates to a method for the prevention or treatment of symptoms of dyskinesie late in a patient, by administering an effective amount of melatonin to the end, and a pharmaceutical composition containing at least a composed effective antipsychotic in quantity to have an effect in a patient with neuroleptic treatment.and melatonin in amount effective to enhance or prevent the development of symptoms of dyskinesie late.